License: Creative Commons Attribution 4.0 PDF - Published Version (598kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-520953
- DOI to cite this document:
- 10.5283/epub.52095
Abstract
Introduction: Cormirnaty® was the first available vaccine in Europe that contains mRNA encoding the spike protein of SARS-CoV2. An enormous peptide commonality and thus molecular mimicry between SARS-CoV2 spike protein and human proteins could be shown. Molecular mimicry could be attributable to SARS-CoV2 associated illness. Objectives: So far saturation rate was not examined in patients ...
Owner only: item control page